A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis

被引:181
|
作者
Krentel, Alison [1 ,2 ]
Fischer, Peter U. [1 ]
Weil, Gary J. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA
[2] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England
来源
PLOS NEGLECTED TROPICAL DISEASES | 2013年 / 7卷 / 11期
基金
比尔及梅琳达.盖茨基金会;
关键词
NEGLECTED TROPICAL DISEASES; RURAL-AREAS; WESTERN PROVINCE; ORISSA STATE; TAMIL-NADU; PROGRAM; INDIA; COMMUNITY; IMPACT; COVERAGE;
D O I
10.1371/journal.pntd.0002447
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The success of programs to eliminate lymphatic filariasis (LF) depends in large part on their ability to achieve and sustain high levels of compliance with mass drug administration (MDA). This paper reports results from a comprehensive review of factors that affect compliance with MDA. Methodology/Principal Findings: Papers published between 2000 and 2012 were considered, and 79 publications were included in the final dataset for analysis after two rounds of selection. While results varied in different settings, some common features were associated with successful programs and with compliance by individuals. Training and motivation of drug distributors is critically important, because these people directly interact with target populations, and their actions can affect MDA compliance decisions by families and individuals. Other important programmatic issues include thorough preparation of personnel, supplies, and logistics for implementation and preparation of the population for MDA. Demographic factors (age, sex, income level, and area of residence) are often associated with compliance by individuals, but compliance decisions are also affected by perceptions of the potential benefits of participation versus the risk of adverse events. Trust and information can sometimes offset fear of the unknown. While no single formula can ensure success MDA in all settings, five key ingredients were identified: engender trust, tailor programs to local conditions, take actions to minimize the impact of adverse events, promote the broader benefits of the MDA program, and directly address the issue of systematic non-compliance, which harms communities by prolonging their exposure to LF. Conclusions/Significance: This review has identified factors that promote coverage and compliance with MDA for LF elimination across countries. This information may be helpful for explaining results that do not meet expectations and for developing remedies for ailing MDA programs. Our review has also identified gaps in understanding and suggested priority areas for further research.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Compliance and efficacy of mass drug administration for elimination of lymphatic filariasis in Egypt
    El Setouhy, Maged
    Aziz, Khaled Abdel
    Ahmed, Ehab S.
    Ramzy, Reda M.
    Weil, Gary J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (06): : 176 - 176
  • [2] The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt
    El-Setouhy, Maged
    Elaziz, Khaled M. Abd
    Helmy, Hanan
    Farid, Hoda A.
    Kamal, Hussein A.
    Ramzy, Reda M. R.
    Shannon, William D.
    Weil, Gary J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (06): : 1069 - 1073
  • [3] Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination
    Alexander, Neal D. E.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2015, 109 (03) : 173 - 174
  • [4] Mass drug administration for elimination of lymphatic filariasis: a discussion
    Wiwanitkit, Somsri
    Wiwanitkit, Viroj
    JOURNAL OF VECTOR BORNE DISEASES, 2011, 48 (03) : 182 - 182
  • [5] Coverage and compliance to mass drug administration for lymphatic filariasis elimination in a district of Kerala, India
    Nujum, Zinia T.
    INTERNATIONAL HEALTH, 2011, 3 (01): : 22 - 26
  • [6] Socioeconomic factors associated with compliance with mass drug administration for lymphatic filariasis elimination in Kenya: Descriptive study results
    Njomo, Doris W.
    Amuyunzu-Nyamongo, M.
    Mukoko, Dunstan A.
    Magambo, Japheth K.
    Njenga, Sammy M.
    ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2012, 5 (02) : 103 - 110
  • [7] Factors influencing compliance to mass drug administration for control of lymphatic filariasis in Tanzania
    Meyrowitsch, D.
    Kisoka, W.
    Mushi, D.
    Malecela, M.
    Simonsen, P.
    Tersboel, B.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2013, 18 : 55 - 55
  • [8] The Role of Personal Opinions and Experiences in Compliance with Mass Drug Administration for Lymphatic Filariasis Elimination in Kenya
    Njomo, Doris W.
    Amuyunzu-Nyamongo, Mary
    Magambo, Japheth K.
    Njenga, Sammy M.
    PLOS ONE, 2012, 7 (11):
  • [9] National Mass Drug Administration Costs for Lymphatic Filariasis Elimination
    Goldman, Ann S.
    Guisinger, Victoria H.
    Aikins, Moses
    Amarillo, Maria Lourdes E.
    Belizario, Vicente Y.
    Garshong, Bertha
    Gyapong, John
    Kabali, Conrad
    Kamal, Hussein A.
    Kanjilal, Sanjat
    Kyelem, Dominique
    Lizardo, Jefrey
    Malecela, Mwele
    Mubyazi, Godfrey
    Nitiema, P. Abdoulaye
    Ramzy, Reda M. R.
    Streit, Thomas G.
    Wallace, Aaron
    Brady, Molly A.
    Rheingans, Richard
    Ottesen, Eric A.
    Haddix, Anne C.
    PLOS NEGLECTED TROPICAL DISEASES, 2007, 1 (01):
  • [10] Impact of mass drug administration for elimination of lymphatic filariasis in Nepal
    Ojha, Chet Raj
    Joshi, Basant
    Prakash, Khagendra K. C.
    Dumre, Shyam Prakash
    Yogi, Keshav Kumar
    Bhatta, Bandana
    Adhikari, Tulasi
    Crowley, Kathryn
    Marasini, Babu Ram
    PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (07):